Aurobindo Pharma's ANDA218949 for Icosapent Ethyl Receives AP Status
Aurobindo Pharma's ANDA218949 for Icosapent Ethyl has received an Abbreviated Approval (AP) status from the FDA.
Therapeutic Area
Therapeutic area intelligence for Omega-3 Fatty Acids with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.